Codiak Biosciences

Epizyme, Inc is a global biopharmaceutical leader focused on developing innovative medicines in oncology, neuroscience, and rare diseases. The company is dedicated to improving lives through cutting-edge research and the development of transformative therapies. Generated from their website's infomation

The ALS Therapy Development Institute (ALS TDI) is a nonprofit biotech organization located in Watertown, Massachusetts, dedicated to ending amyotrophic lateral sclerosis (ALS) through comprehensive drug discovery research. As the world's largest lab focused solely on ALS, it aims to develop multiple effective treatments for the disease, fueled by the support of the ALS community. With a relentless commitment to research, ALS TDI advances potential treatments into clinical trials while also gathering vital data from the ALS Research Collaborative (ARC) to inform its efforts. The organization operates under the belief that ALS is not an incurable disease, but rather an underfunded one, and is determined to transform the landscape of ALS treatment through innovative solutions. Generated from the website

Arkuda is comprised of passionate and experienced team members who are dedicated to improving the lives of people affected by neurodegenerative disease. Armed with deep expertise in biology and the ab